Research Projects & Grants

For Profit Organization

  • GOG-263: Randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer treated with initial radical hysterectomy and pelvic lymphadenectomy, Role: Investigator, Southwest Oncology Group, (09/2024 - 09/2025) Status: Approved
  • Southwest Oncology Group (SWOG) S1609: DART: Dual Anti-CTLA-4 and Anti-PD-1 blockade in rare tumors, Role: Investigator, Southwest Oncology Group, (12/2024 - 12/2025) Status: Approved
  • SWOG / NRG-GY009: A Randomized, Phase II/III Study of Pegylated Lipsomal Doxorubicin and CTEP-Supplied Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant Ovarian Cancer, Role: Investigator, Southwest Oncology Group, (12/2019) Status: Completed
  • SWOG -EAY131: Molecular analysis for therapy choice (MATCH), Role: Investigator, Southwest Oncology Group, (08/2019 - 08/2020) Status: Completed
  • SWOG 9318. Recombinant Human Erythropoietin (r-HuEPO) as an Adjunct to Radiation Therapy and Cisplatin for Patients with Stages II-B, III and IV-A Carcinoma of the Cervix. Phase II, Role: Investigator, Southwest Oncology Group, (01/2005 - 01/2006) Status: Completed
  • A Double-blind, Multicenter, Parallel Study Comparing the Efficacy and Safety of Oral Granisetron Hydrochloride 2 mg with Intravenous Ondansetron Hydrochloride 32 mg Given Once Prior to Chemotherapy in the Prevention of Nausea and Vomiting Induced by Cisplatin-based Chemotherapy, Role: PI, Smithkline Beecham, (01/1996 - 01/1997) Status: Completed

Internal

  • Investigator initiated: Conventional prophylactic regimen of oral dexamethasone versus short-course intravenous dexamethasone in preventing paclitaxel-related hypersensitivity reactions in breast and gynecologic-oncology patients: A prospective, randomized, open-label study, Role: Investigator, LLU Dept. of Gynecology & Obstetrics, (02/2024 - 01/2025) Status: Completed
  • Investigator initiated: Retrospective analysis to determine the incidence of Occult Cervical cancer in patients with Adenocarcinoma in situ at LLU, Role: Investigator, LLU Dept. of Gynecology & Obstetrics, (02/2019) Status: Approved
  • Sexual and marital dysfunction in women with gynecologic cancer, Role: Investigator, LLU Dept. of Gynecology & Obstetrics, (06/2015 - 06/2016) Status: Completed
  • Collection of female reproductive tissue samples, Role: Investigator, LLU Basic Science, (01/2015 - 01/2016) Status: Completed
  • Compassionate use of everolimus: Individual patient program (IPP) for treatment of recurrent progressive clear cell endocervical cancer with everolimus, Role: Investigator, LLU Dept. of Gynecology & Obstetrics, Status: Completed